About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 419 record(s)
Req # A-2020-000168
Adverse Reaction Report (AER) for botulinum toxin A . Report number: E2B_02932672.Organization: Health Canada
August 2020
Req # A-2020-000175
Adverse Reaction Report (AER) for botulinum toxin A. Report number: E2B_02985683.Organization: Health Canada
August 2020
Req # A-2020-000204
Adverse Reaction Report (AER) for PMS-AZITHROMYCIN. Report number: E2B_02972093.Organization: Health Canada
August 2020
Req # A-2020-000210
Adverse Reaction Report (AER). Report numbers: 000504926, E2B_02938670, E2B_02403401, 000725458.Organization: Health Canada
August 2020
Req # A-2020-000225
Adverse Reaction Report (AER) for M-M-R II. Report number: 000676417.Organization: Health Canada
August 2020
Req # A-2020-000231
Adverse Reaction Report (AER) for PROMETRIUM. Report numbers: 000664347, E2B_00451784.Organization: Health Canada
August 2020
Req # A-2020-000248
Adverse Reaction Report (AER) for CLOPIDOGREL BISULFATE. Report number: 729743.Organization: Health Canada
August 2020
Req # A-2020-000288
Adverse Reaction Report (AER) for botulinum toxin type A. Report number: E2B_02466259.Organization: Health Canada
August 2020
Req # A-2020-000336
Adverse Reaction Report (AER) for SARILUMAB. Report number: E2B_02917832.Organization: Health Canada
August 2020
Req # A-2020-000338
Adverse Reaction Report (AER) for ANTI-THYMOCYTE GLOBULIN (RABBIT). Report numbers: E2B_02764378, E2B_02233985, E2B_02799565.Organization: Health Canada
August 2020